Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
25 hedge funds and large institutions have $16.1M invested in Marrone Bio Innovations, Inc. in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 3 closing their positions.
96% more capital invested
Capital invested by funds: $8.2M → $16.1M (+$7.86M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
4% more funds holding
Funds holding: 24 → 25 (+1)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$300K |
| 2 |
SIM
Spark Investment Management
New York
|
+$26.8K |
| 3 |
AF
Allworth Financial
Folsom,
California
|
+$12.2K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$4.23K |
| 5 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
+$2.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
-$796K |
| 2 |
Primecap Management
Pasadena,
California
|
-$167K |
| 3 |
Millennium Management
New York
|
-$56K |
| 4 |
Goldman Sachs
New York
|
-$37K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$29.5K |
MBII Hedge Fund Activity: Q3 2016 in Review
25 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2016, worth a combined $16.1M — up 96% from $8.2M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MBII positions and 3 closed out — a net gain of 1 holder — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Ardsley Advisory Partners, adding an estimated $300K. The largest seller was Senvest Management, cutting an estimated $796K.
- 25 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2016, up from 24 in Q2 2016.
- Funds reported $16.1M of Marrone Bio Innovations, Inc. stock for Q3 2016, up 96% quarter-over-quarter.
- 4 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2016 and 3 closed out, a net change of +1 holder.
- The largest Marrone Bio Innovations, Inc. buyer in Q3 2016 was Ardsley Advisory Partners, an estimated $300K added.
- The largest Marrone Bio Innovations, Inc. seller in Q3 2016 was Senvest Management, an estimated $796K sold.
Based on aggregated 13F filings for Q3 2016.